Email Michael Daniels

NASDAQ:EIGR Investor Notice: Investigation over Possible Securities Laws Violations by Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy